miRNAs associated with chemo-sensitivity in cell lines and in advanced bladder cancer - Wikidata - wikimedia - TriplyDB

miRNAs associated with chemo-sensitivity in cell lines and in advanced bladder cancer

miRNAs associated with chemo-sensitivity in cell lines and in advanced bladder cancer

http://www.wikidata.org/entity/Q34407238

about

The noncoding RNA expression profile and the effect of lncRNA AK126698 on cisplatin resistance in non-small-cell lung cancer cell Screening of potential biomarkers for chemoresistant ovarian carcinoma with miRNA expression profiling data by bioinformatics approach.Prognostic and predictive biomarkers: tools in personalized oncology.Profiling of long non-coding RNAs identifies LINC00958 and LINC01296 as candidate oncogenes in bladder cancer nc886, a non-coding RNA of anti-proliferative role, is suppressed by CpG DNA methylation in human gastric cancer.MicroRNA-7 sensitizes non-small cell lung cancer cells to paclitaxel.MicroRNA-25 regulates small cell lung cancer cell development and cell cycle through cyclin E2 Novel functions and targets of miR-944 in human cervical cancer cells.Links between the oncoprotein YB-1 and small non-coding RNAs in breast cancer.miR-101 suppresses vascular endothelial growth factor C that inhibits migration and invasion and enhances cisplatin chemosensitivity of bladder cancer cells.MicroRNA-203 Is a Prognostic Indicator in Bladder Cancer and Enhances Chemosensitivity to Cisplatin via Apoptosis by Targeting Bcl-w and Survivin Repression of the miR-93-enhanced sensitivity of bladder carcinoma to chemotherapy involves the regulation of LASS2.Reduced expression of miRNA-27a modulates cisplatin resistance in bladder cancer by targeting the cystine/glutamate exchanger SLC7A11.MiR-21 as prognostic biomarker in head and neck squamous cell carcinoma patients undergoing an organ preservation protocol.MicroRNAs in personalized cancer therapy.miRNA panels as biomarkers for bladder cancer.The role of genomics in the management of advanced bladder cancer.miR-138-Mediated Regulation of KINDLIN-2 Expression Modulates Sensitivity to Chemotherapeutics.Molecular markers in bladder cancer: Novel research frontiers.CpG location and methylation level are crucial factors for the early detection of oral squamous cell carcinoma in brushing samples using bisulfite sequencing of a 13-gene panel.Prognostic and predictive miRNA biomarkers in bladder, kidney and prostate cancer: Where do we stand in biomarker development?Epigenetic alternations and cancer chemotherapy response.MicroRNA-944 Affects Cell Growth by Targeting EPHA7 in Non-Small Cell Lung Cancer.Gene Expression Profile of the Clinically Aggressive Micropapillary Variant of Bladder Cancer.Regulation of growth of human bladder cancer by miR-192.Clinical risk stratification in patients with surgically resectable micropapillary bladder cancer.The role of phenethyl isothiocyanate on bladder cancer ADM resistance reversal and its molecular mechanism.Exploitation of Gene Expression and Cancer Biomarkers in Paving the Path to Era of Personalized Medicine.miR-199a-3p and miR-214-3p improve the overall survival prediction of muscle-invasive bladder cancer patients after radical cystectomy.MicroRNA Profile to Predict Gemcitabine Resistance in Bladder Carcinoma Cell Lines.Roles of mitochondrial transcription factor A and microRNA-590-3p in the development of bladder cancer.Improved risk stratification in myeloma using a microRNA-based classifier.MiR-944 functions as a novel oncogene and regulates the chemoresistance in breast cancer.MiR-1260b inhibitor enhances the chemosensitivity of colorectal cancer cells to fluorouracil by targeting PDCD4/IGF1

P2860

Q28533535-97AAAD01-4397-4D6D-A548-BD0D274BE1F7 Q31029533-76524F00-D63A-433F-8A6A-2B4CB3AD8294 Q33651583-E4777ADA-2614-44F9-98E4-FEBFE7347552 Q33670900-8298B460-9EC4-4B47-9F11-95E02E318E03 Q33977148-049F3D75-5A61-46C6-B3EE-94ACB80C1DC4 Q34293127-05F44D31-4C42-477C-90B9-BA1FCD7CB4C6 Q34733320-BF872029-15E7-478A-85E1-0D6F7C632ED8 Q34776143-1D1484B4-76F3-4D7F-B815-AC1806F34D81 Q35048886-B29BEBCE-0FB6-49C6-AA44-B50087F19670 Q35557027-52605D89-0145-4D73-BBBB-A2395FDDF7C9 Q35850227-FF4C6F69-BF1D-4C4B-90F8-D7E849C074F2 Q36766823-77DAE14A-794E-4699-A922-08B87799B18C Q37682756-71D406C8-7D8E-4AE0-8AE6-AE9B80185D72 Q37706078-EC5FBE47-2B21-42A8-BD44-7DFD290B7ABA Q38196460-D436D964-7578-4193-B418-369C39D2EF96 Q38239829-1D630F87-528B-4EB5-A5F7-4C49F4985D6A Q38342992-A031F49C-8D8D-4C7B-9BF3-FAB5BC943E26 Q38512093-FE22E940-CB1D-4881-84D5-650325B4ECFC Q38520403-9BC26FD9-D421-4E10-819D-CB2241806415 Q38621270-96CA30D3-B21D-4402-827E-777F9416D02A Q38667456-A009DE0D-CF65-4134-A182-3BD66CA38F51 Q38680431-8076C5AF-E939-475D-B1BF-2C4A33136B9D Q38743285-9BB69305-5F79-4245-9C5F-F991A5101545 Q38893600-37F08B1B-B1A8-4BCE-8EA0-26E70FC24B3E Q38922382-A07709AD-CE5C-4406-B74E-D0B003E48F84 Q38983687-0D891F9E-D484-4878-8F32-AC69CFB9C060 Q39180799-6BC82885-A825-490B-A210-4472DD5C1BAA Q41603225-66127449-610D-41BE-8405-4E80A26808C0 Q42373335-FCC8C77C-99E0-429E-8E4F-D86643EADE79 Q42554135-F79FA7C3-6BC8-4FDC-A063-FE7EEEFCC017 Q42959491-9B9207A1-8F21-47FC-A9DB-A6B2EC7EC0BB Q53109542-6B5412BC-E343-4C14-B373-7E3445675DBE Q53369992-2F498BE7-F147-4BDF-B210-2BFDDAFCB397 Q57144441-7DC29862-E04E-4CB5-ABB6-09658BC5D878

P2860

miRNAs associated with chemo-sensitivity in cell lines and in advanced bladder cancer

http://www.wikidata.org/entity/Q34407238

description

2012 nî lūn-bûn

@nan

2012 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած

@hyw

2012 թվականի սեպտեմբերին հրատարակված գիտական հոդված

@hy

2012年の論文

@ja

2012年論文

@yue

2012年論文

@zh-hant

2012年論文

@zh-hk

2012年論文

@zh-mo

2012年論文

@zh-tw

2012年论文

@wuu

name

miRNAs associated with chemo-sensitivity in cell lines and in advanced bladder cancer

@ast

miRNAs associated with chemo-sensitivity in cell lines and in advanced bladder cancer

@en

miRNAs associated with chemo-sensitivity in cell lines and in advanced bladder cancer

@nl

type

label

miRNAs associated with chemo-sensitivity in cell lines and in advanced bladder cancer

@ast

miRNAs associated with chemo-sensitivity in cell lines and in advanced bladder cancer

@en

miRNAs associated with chemo-sensitivity in cell lines and in advanced bladder cancer

@nl

prefLabel

miRNAs associated with chemo-sensitivity in cell lines and in advanced bladder cancer

@ast

miRNAs associated with chemo-sensitivity in cell lines and in advanced bladder cancer

@en

miRNAs associated with chemo-sensitivity in cell lines and in advanced bladder cancer

@nl

P1433

Q34407238-20D3848B-7669-4544-BDC4-B34142476DD9

P1476

Q34407238-8C274F42-3327-48F6-990C-4AB0A9B3437E

P2093

Q34407238-226281E8-E825-436C-8DE4-3271695C8694

Q34407238-885592C1-2B2A-449B-ABCC-D1B7B49C70EC

Q34407238-A831D071-F46F-4D32-AF57-EBFFC68F2C81

Q34407238-B12FE9DF-C5A3-46D1-B57C-B1CA3D77B767

Q34407238-BBD33A2E-3B46-4783-9806-E587BB9F5939

Q34407238-D011CE30-6F59-45C4-8707-892167072EB2

P2860

Q34407238-08CA521B-9479-488F-857F-1B36E2163012

Q34407238-0BCF0FA9-D1A0-4D8D-ABA5-DE1750810F31

Q34407238-0DFB4769-75D9-497C-B2D3-F8A41EDAAD95

Q34407238-21534283-A320-4AFD-8A94-FF467F46C18D

Q34407238-2FBA7E95-6C37-4647-BF38-E6130D17C87E

Q34407238-31681D92-1187-48E0-8278-36573CE0EB74

Q34407238-329E5ED1-9B88-46B7-A792-19D22C12252F

Q34407238-3607AD3B-14CB-405F-A18C-D5ACA49ED741

Q34407238-40693DBC-8018-4CEE-B998-E7B2024AC5FD

Q34407238-459DD31C-72F1-4C52-87AB-64EA46FC1B57

P2888

Q34407238-7D315FA3-827B-49A4-A7C2-A73AF2A6C923

P304

Q34407238-D6AB3879-B997-4303-958D-6C095FD6D34E

P31

Q34407238-528AE7F7-21D4-45C5-A65D-5B45FE1ADE7C

P356

Q34407238-0C358BBA-9772-436F-B32E-692D9A053042

P478

Q34407238-1B132EF2-AD08-48DC-B918-2FB659700C62

P50

Q34407238-4A097AC4-70C2-4000-B545-FAF823B40A6C

Q34407238-88DCD7E6-1600-4BBB-AC70-9BB23AC24791

Q34407238-A1544F45-2BDD-41F8-B293-DE3E21662426

P577

Q34407238-A65A1AF2-8243-4B9A-8B64-257A74714AE2

P5875

Q34407238-FBE9528F-ED36-4D9D-87B5-6C702B956FAE

P6179

Q34407238-6517799C-A613-4B32-9B25-0DA10B7E1293

P698

Q34407238-7D87AFD1-3235-4C34-94D7-AABC01EDA964

P932

Q34407238-D9FE80EF-E85B-4FE2-895A-D308485760ED

P356

P1433

BMC Medical Genomics

P1476

miRNAs associated with chemo-sensitivity in cell lines and in advanced bladder cancer

@en

P2093

Arndt Hartmann

http://www.w3.org/2001/XMLSchema#string

Dan Theodorescu

http://www.w3.org/2001/XMLSchema#string

Karin Birkenkamp-Demtroder

http://www.w3.org/2001/XMLSchema#string

Marie Stampe Ostenfeld

http://www.w3.org/2001/XMLSchema#string

Michael Borre

http://www.w3.org/2001/XMLSchema#string

Torben F Ørntoft

http://www.w3.org/2001/XMLSchema#string

P2860

Cooperative and individualistic functions of the microRNAs in the miR-23a~27a~24-2 cluster and its implication in human diseases

Mammalian miRNA RISC recruits CAF1 and PABP to affect PABP-dependent deadenylation

MicroRNA-138 modulates DNA damage response by repressing histone H2AX expression

Human microRNA genes are frequently located at fragile sites and genomic regions involved in cancers

Precursor miR-886, a novel noncoding RNA repressed in cancer, associates with PKR and modulates its activity.

Role of MicroRNA miR-27a and miR-451 in the regulation of MDR1/P-glycoprotein expression in human cancer cells

New guidelines to evaluate the response to treatment in solid tumors. European Organization for Research and Treatment of Cancer, National Cancer Institute of the United States, National Cancer Institute of Canada

MicroRNA expression profiles classify human cancers

Gemcitabine and cisplatin versus methotrexate, vinblastine, doxorubicin, and cisplatin in advanced or metastatic bladder cancer: results of a large, randomized, multinational, multicenter, phase III study

Genomic profiling of microRNAs in bladder cancer: miR-129 is associated with poor outcome and promotes cell death in vitro

P2888

P304

40

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1186/1755-8794-5-40

http://www.w3.org/2001/XMLSchema#string

P478

5

http://www.w3.org/2001/XMLSchema#string

P50

Iver Nordentoft

P577

2012-09-06T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

230809769

http://www.w3.org/2001/XMLSchema#string

P6179

1047078610

http://www.w3.org/2001/XMLSchema#string

P698

22954303

http://www.w3.org/2001/XMLSchema#string

P932

3473298

http://www.w3.org/2001/XMLSchema#string